Greg Ganse
Chief Executive Officer
Biography
With over 20 years of pharmacy experience, Greg leads operations across the nine Altruix pharmacies. Greg was formerly the President, CEO and owner of Ganse Apothecary, an independent family pharmacy, which was acquired by Altruix in 2022.
Prior to leading Ganse Apothecary, he spent time working for Teva Pharmaceuticals and Covidien Healthcare. Greg’s passion for organizational development and serving a population that is underfunded and underserved is what led to the success of his pharmacy.
Greg graduated from Muhlenberg College in 2001 with a BA in Entrepreneurial Studies and German Language and Literature.
Altruix News
Congrats to our two URAC-accredited specialty pharmacy teams in Lancaster, PA, and Trevose, PA.
The latest data shows that only 10% of the people[...]
If you or a loved one have struggled with[...]
Legal opioids, including the synthetic drug fentanyl, are a big[...]
Schizophrenia is a chronic brain disease where the affected person[...]
Whether the addiction is to alcohol, opioids, or some other[...]
Americans use their corner drugstore to fulfill all kinds of[...]
Local Altruix pharmacies will fill prescriptions for extended-release buprenorphine injection for patients with moderate to severe opioid use disorder.
Terrapin Pharmacy, located in Annapolis, MD, today announced that it is changing its name to Altruix.
Ganse Apothecary, located in Lancaster, PA, today announced that it is changing its name to Altruix. Altruix consists of the combined operations of Terrapin Pharmacy, Bank's Apothecary, and the former Ganse Apothecary, serving over 23,000 individuals across 23 states.
